test

Delmer Dee Raibourn III

@Avidity Partners Management Lp

Latest period2024 - Q3ReportedManaged Assets$1.96BTotal holdings81
Assets growth rate-16.7%Assets growth rate (2-Q avg)-20.41%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Avidity Partners Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 81 positions.

Assets under management

The assets under management (AUM) of Avidity Partners Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.96B in assets, with a quarterly growth rate of -16.7% and a 2-quarter average growth rate of -20.41%. The portfolio is managed by Delmer Dee Raibourn III, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
DHRDanaher Corporation
Recent Activity
Decreased -36.66%
1.35%
$26.412M
95,000 shares@ $278.02 avg price
JANXJanux Therapeutics Inc
Recent Activity
Decreased -33.11%
1.31%
$25.532M
562,000 shares@ $45.43 avg price
NMRANeumora Therapeutics Inc.
Recent Activity
1.22%
$23.778M
1.8M shares@ $13.21 avg price
KYMRKymera Therapeutics Inc
Recent Activity
New Position
1.21%
$23.665M
500,000 shares@ $47.33 avg price
BHVNBiohaven Ltd
Recent Activity
Increased 3.34%
1.19%
$23.236M
465,000 shares@ $49.97 avg price
BMRNBiomarin Pharmaceutical Inc
Recent Activity
New Position
1.15%
$22.493M
320,000 shares@ $70.29 avg price
ARGXArgenx Se
Recent Activity
Decreased -36.85%
1.06%
$20.707M
38,200 shares@ $542.08 avg price
INCYIncyte Corp
Recent Activity
Decreased -41.75%
1.04%
$20.366M
308,110 shares@ $66.1 avg price
ABBVAbbvie Inc
Recent Activity
Decreased -64%
1.01%
$19.748M
100,000 shares@ $197.48 avg price
ORKAOruka Therapeutics Inc
Recent Activity
New Position
0.99%
$19.386M
790,926 shares@ $24.51 avg price